![Overall survival among with clinically significant portal hypertension... | Download Scientific Diagram Overall survival among with clinically significant portal hypertension... | Download Scientific Diagram](https://www.researchgate.net/profile/Simone-Conci/publication/332469524/figure/fig3/AS:883572684623872@1587671552119/Overall-survival-among-with-clinically-significant-portal-hypertension-according-to-ALBI.png)
Overall survival among with clinically significant portal hypertension... | Download Scientific Diagram
![Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma - JHEP Reports Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma - JHEP Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/91a9b775-7f0f-435e-a5c6-56dc20908dd9/fx1_lrg.jpg)
Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma - JHEP Reports
![Predicting the risk of post-hepatectomy portal hypertension using a digital twin: A clinical proof of concept - Journal of Hepatology Predicting the risk of post-hepatectomy portal hypertension using a digital twin: A clinical proof of concept - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/60b159f2-2cf1-46b5-bb55-8a9dbe987886/fx1_lrg.jpg)
Predicting the risk of post-hepatectomy portal hypertension using a digital twin: A clinical proof of concept - Journal of Hepatology
![The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis - Reiberger - - Hepatology Communications - Wiley Online Library The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis - Reiberger - - Hepatology Communications - Wiley Online Library](https://aasldpubs.onlinelibrary.wiley.com/cms/asset/644c21e1-979e-4e5f-b2c7-a769ddae6085/hep41855-toc-0001-m.jpg)
The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis - Reiberger - - Hepatology Communications - Wiley Online Library
![Should patients with clinically significant portal hypertension be on beta-blockers? | Liver Fellow Network Should patients with clinically significant portal hypertension be on beta-blockers? | Liver Fellow Network](https://data.liverfellow.org/wp-content/uploads/2021/04/lizzie-BB.png)
Should patients with clinically significant portal hypertension be on beta-blockers? | Liver Fellow Network
![Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension - ScienceDirect Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827820303688-fx1.jpg)
Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension - ScienceDirect
![Algorithm to rule out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multicentre study | Gut Algorithm to rule out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multicentre study | Gut](https://gut.bmj.com/content/gutjnl/65/6/1057/F1.large.jpg)
Algorithm to rule out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multicentre study | Gut
![Frontiers | Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis | Medicine Frontiers | Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis | Medicine](https://www.frontiersin.org/files/Articles/803119/fmed-08-803119-HTML/image_m/fmed-08-803119-g001.jpg)
Frontiers | Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis | Medicine
![Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis - HPB Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis - HPB](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/82383eaa-856d-4177-9f48-d9018e1bffed/gr1.jpg)
Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis - HPB
![Serum keratin 19 (CYFRA21-1) links ductular reaction with portal hypertension and outcome of various advanced liver diseases | BMC Medicine | Full Text Serum keratin 19 (CYFRA21-1) links ductular reaction with portal hypertension and outcome of various advanced liver diseases | BMC Medicine | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12916-020-01784-7/MediaObjects/12916_2020_1784_Fig2_HTML.png)
Serum keratin 19 (CYFRA21-1) links ductular reaction with portal hypertension and outcome of various advanced liver diseases | BMC Medicine | Full Text
![Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension - The Lancet Gastroenterology & Hepatology Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension - The Lancet Gastroenterology & Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9b7b868e-4bb1-4ac1-bb80-3cab1602e78f/gr1_lrg.jpg)
Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension - The Lancet Gastroenterology & Hepatology
Juan Turnes on Twitter: "2/2 We can use #elastography rule of five + platelet count to identify those with clinically significant portal hypertension: ➡️ >25 kPa ➡️ 20-25 kPa & <150 platelets
![Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease - Clinics in Liver Disease Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease - Clinics in Liver Disease](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/46452bad-1dae-40f3-85f9-4c0a8cc6bdaa/gr3.jpg)